Position in ERAS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$119,106,123
+$22,088,433 QoQ
Shares Held
6,501,426
+8.4% QoQ
Ownership
1.86%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. ERAS ranks #42 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,106,123 | 6,501,426 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $97,017,690 | 5,996,149 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,325,965 | 4,926,335 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $10,569,867 | 4,848,563 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,141,264 | 4,835,642 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $6,518,256 | 4,757,852 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,470,245 | 4,569,819 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,292,365 | 4,502,698 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,816,062 | 3,311,891 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,896,578 | 1,891,543 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,859,370 | 1,811,911 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,379,324 | 1,715,393 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,457,943 | 1,615,197 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,587,330 | 1,524,030 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,284,150 | 1,226,021 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,962,168 | 1,148,996 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,313,174 | 774,358 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,218,049 | 723,029 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,198,144 | 397,827 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,985,510 | 376,320 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||